#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thyroid cancer metastatic Cytokine release syndrome Mitochondrial myopathy Gastrointestinal neuroendocrine tumour Allogenic stem cell transplantation Spinal cord injury cervical Ewing's sarcoma recurrent Deafness neurosensory Hereditary angioedema with C1 esterase inhibitor deficiency Desmoid tumour Metastases to peritoneum Chorioretinitis Pleural mesothelioma malignant Philadelphia positive acute lymphocytic leukaemia Plasma cell myeloma refractory More trials…

    Learn about Rare Diseases

    Anaplastic thyroid cancer – Trials in Disease Langerhans cell sarcoma – Basic Information Waldenstrom’s macroglobulinaemia – Life with Disease Factor VIII deficiency – Diagnostics Mast cell activation syndrome MELAS syndrome – Life with Disease Systemic sclerosis pulmonary – Life with Disease Optic glioma – Treatment CADASIL – Basic Information Myelodysplastic syndrome with excess blasts – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Specific Nucleic Acid Sna-Ebv Sodium 2-Hydroxylinoleate Cilastatin Sodium Mbs2320 Almagate Recombinant Interferon Beta-1B Asp1570 Nms-03305293 Crn04894 INSULIN DEGLUDEC Salbutamol Sulfate Ph. Eur. Omeprazole Varegacestat Atrasentan Hydrochloride Vanglusagene Ensiparvovec Orismilast Pristinamycin Zidovudine Anifrolumab TRV045 More therapies…

    Learn about Your Condition

    Gender dysphoria Peritoneal sarcoma Anogenital dysplasia Limb reduction defect Allergic respiratory disease Retinopathy proliferative Hypertrophic scar Oropharyngeal cancer Thyroid mass Venous thrombosis limb Malignant melanoma of eyelid Propionic acidaemia Encephalitis autoimmune Acute kidney injury Neuropathy peripheral More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Sanitaria Universitaria Giuliano Isontina

Azienda Sanitaria Universitaria Giuliano Isontina

Strada Di Fiume 447, Trieste, 34149, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effects of NSC001 and Trospium Chloride for Patients with Mild to Moderate Alzheimer’s Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • (S)-2-ETHYL-8-METHYL-1-THIA-4,8-DIAZASPIRO[4.5]DECAN-3-ONE
    • Trospium Chloride
    Austria Czechia Germany Italy

  • Study to Diagnose Cardiac Amyloidosis in Patients with Monoclonal Component Using Florbetaben (18F) PET-CT

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Florbetaben (18F)
    Italy

  • Study on Revumenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Revumenib
    • Azacitidine
    • Venetoclax
    Austria Belgium Denmark Estonia Finland France +8

  • Study on the Effectiveness and Safety of Efgartigimod IV for Adults with Primary Immune Thrombocytopenia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Efgartigimod Alfa
    Austria Bulgaria Croatia Czechia France Germany +8

  • Study on Luspatercept for Treating Anemia in Patients with Myelodysplastic Syndromes (MDS) with del5q, Resistant to Prior Treatments and Needing Blood Transfusions

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Luspatercept
    Italy

  • Study of gemtuzumab ozogamicin with chemotherapy for adults aged 18-60 with newly diagnosed favorable-intermediate-risk acute myeloid leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Treosulfan
    • Daunorubicin Hydrochloride
    • Gemtuzumab Ozogamicin
    Italy

  • Study on Atezolizumab for Patients with Malignant Pleural Mesothelioma After Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pleural mesothelioma malignant
    Investigated Drugs:
    • Atezolizumab
    Italy

  • Study of Sonidegib for Patients with Nevoid Basal Cell Carcinoma Syndrome and Sporadic Basal Cell Carcinoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Sonidegib
    Italy

  • Study of Rituximab and Golcadomide for Older Frail Patients with Diffuse Large B-cell Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Golcadomide
    • Rituximab
    Italy

  • Study of Vemurafenib and Rituximab for Untreated Hairy Cell Leukemia Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hairy cell leukaemia
    Investigated Drugs:
    • Vemurafenib
    • Cladribine
    • Rituximab
    Italy
Previous Page
1 2 3 4 5 … 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!